Participants 324 422 8
three-centre study investigated the preference of cystic fibrosis (CF) patients for these products
Participants 524 722 7
Fifty-nine patients with a mean age 10 years (range 3-17) took Creon 8,000 ms for 14 days and were then randomised to 28 days of Creon 8,000 ms followed by 28 days of Creon 10,000 MMS, or vice versa
Participants 835 876 3
51 of 54 patients who completed the study
Participants 1298 1309 4
CF children
